IQI
WGS icon

Integrated Quantitative Investments’s GeneDx Holdings WGS Stock Holding History

Integrated Quantitative Investments’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,613
Closed -$282K – 512
2025
Q3 		$282K Sell
2,613
-1,487
-36% -$162K 0.08% 276
2025
Q2 		$378K Sell
4,100
-9,612
-70% -$755K 0.11% 261
2025
Q1 		$1.21M Buy
13,712
+9,012
+192% +$782K 0.6% 40
2024
Q4 		$361K Buy
+4,700
New +$328K 0.18% 181

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Summit Partners Public Asset Management
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Integrated Quantitative Investments's WGS Position: Q4 2025 in Review

Integrated Quantitative Investments sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 2,613 shares — an estimated $282K sold.

Integrated Quantitative Investments first reported a position in WGS in Q4 2024 and held it in 4 quarters. The position peaked at $1.21M in Q1 2025. 287 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Integrated Quantitative Investments reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 2,613 GeneDx Holdings shares in Q4 2025, an estimated $282K.
  • Integrated Quantitative Investments first reported a position in GeneDx Holdings in Q4 2024 and held it in 4 quarters.
  • Integrated Quantitative Investments's GeneDx Holdings position peaked at $1.21M in Q1 2025.
  • 287 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Integrated Quantitative Investments's 13F filing for Q4 2025, filed 12 Feb 2026.